Switzerland’s digital health industry is contracting as it matures.
According to new research by Health-Trends, a Swiss research organization and think tank focused on health innovation, the market now counts 159 startups, a figure which represents a 20% drop from 199 players in October 2023, and a slight 4% decline from 166 startups in 2025.
Digital health startups are young companies that use digital technologies, including software, artificial intelligence (AI), mobile applications, connected devices, and data analytics, to improve healthcare delivery, prevention, diagnosis, treatment or patient outcomes.
This decline in the number of digital health startups over the past years shows a sector consolidating into fewer, more integrated platforms, where established healthcare groups and international buyers gain influence.
Relevant transactions in 2025 and 2026 include:
- Swedish investment group Storskogen completing the acquisition of a majority stake in LEP AG, a Swiss provider of digital healthcare documentation solutions and nursing intervention catalogues, in August 2025;
- EssilorLuxottica, a Franco-Italian multinational company specializing in vision care, eyewear, and medtech, acquiring RetinAI, which builds tools for large-scale retinal images and biomarker datasets, in October 2025;
- The business combination of Relief Therapeutics and NeuroX Group and the creation of MindMaze Therapeutics, which develops and commercializes digital treatments for neurological diseases and brain disorders, in October 2025; and
- Lucerne-based Helvero eHealth Group, which acquired all shares in Basel-based healthcare software specialist Compass Information Technologie AG, in July 2026.
Several other deals are underway, including:
- The merger between Swiss digital health platforms Compassana and Well, announced in August 2026, to form Compassana-Well and offer a shared platform gathering medical information for patients in one accessible space, linking stakeholders and enabling electronic health record access; and
- Israel-based wellness group movement acquiring the technology and intellectual property assets of Swiss digital health company dacadoo, announced November 2026.
Switzerland’s digital health sector
Switzerland has developed a dynamic digital health sector, supported by world-class healthcare institutions, a strong pharmaceutical and life sciences industry, deep tech expertise, and substantial private capital.
Investors consistently favor the health sector, which have ranked among the biggest recipients of startup funding in the country over the past years.
In 2025, health secured the largest share of venture capital (VC) in Switzerland, raising approximately CHF 1.5 billion and representing 44% of total investment, according to EY. In terms of deal activity, the health sector led with 147 financing rounds, followed by software and analytics with 135 rounds.

Within health, biotech continued to capture the largest share of funding, securing CHF 818 million across 62 deals in 2025, or 56% of the sector’s total volume. Medtech startups raised CHF 369 million across 50 deals, an increase of CHF 94 million compared to the previous year, despite one fewer deal. Finally, care startups attracted CHF 272 million in 23 deals, recording a more than tenfold increase in volume relative to 2024’s CHF 26 million.
Biotech covers startups centered around pharmaceuticals, biological therapies, and drug discovery; medtech focuses on companies building medical devices, diagnostic tools, and clinical hardware or software, consistently rank among the biggest recipients of startup funding in the country; and care involves startups transforming healthcare delivery and patient services, including telemedicine, digital therapeutics, and chronic disease management.
Prominent Swiss startups in digital health include domo.health, and Aktiia.
domo.health is a Swiss digital health and health technology company that provides a unified platform connecting homecare, clinical practice, and medical research. Based in the EPFL Innovation Park, a high-tech campus and deep tech innovation hub located on the École Polytechnique Fédérale de Lausanne (EPFL) campus in Lausanne, domo.health is used by more than 200 organizations.
Aktiia is the company behind Hilo, a medical-grade, wearable blood pressure monitoring system. Hilo is approved by the US Food and Drug Administration (FDA) and CE marked in the European Union as a medical device. It’s trusted by more than 200,000 people worldwide and supported by 14 clinical studies, including four validation studies.
Swiss Digital Health Startup Map 2026

Featured image: Edited by Fintech News Switzerland, based on image by RSplaneta via Magnific

